ArticleScientific reports2025
Tb doped carbon dots as a platform for fluorescence ratiometric and colorimetric sensor for deferasirox.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Tb doped carbon dots (Tb-CDs) were synthesized by a simple hydrothermal method and the existence of Tb in the obtained CDs was confirmed by the several characterization methods. Tb-CDs were exploited to design a ratiometric fluorescence sensor for deferasirox (DFX) assay. CDs and Tb acted as reference and sensing probs in the sensor. In the presence of DFX, the fluorescence intensity of CDs remained unchanged, while Tb emission increased. The fluorescence ratio of Tb to CDs was proportional to the DFX concentration at the range of 0.1 to 2.5 µM. Additionally, the fluorescence color altered from blue (CDs emission) to green (Tb emission) with increasing DFX concentration. We employed this color variation to establish a smartphone based sensor for the DFX detection. The linear range of established sensor was 0.5-15 µM. The detection limit (3S) for the ratiometric and smartphone based sensor was calculated to be 0.08 and 0.4 µM, respectively. Both sensors were applied to measure DFX in human serum samples with satisfactory results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.